Discovery of nonnucleoside inhibitors of polymerase from infectious pancreatic necrosis virus (IPNV)

Melissa Bello-Pérez,1 Alberto Falcó,1 Vicente Galiano,2 Julio Coll,3 Luis Perez,1 José Antonio Encinar1 1Molecular and Cell Biology Institute (IBMC), Miguel Hernández University (UMH), Elche, Spain; 2Department of Physics and Computer Architecture, Miguel...

Full description

Bibliographic Details
Main Authors: Bello-Pérez M, Falco A, Galiano V, Coll J, Perez L, Encinar JA
Format: Article
Language:English
Published: Dove Medical Press 2018-07-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/discovery-of-nonnucleoside-inhibitors-of-polymerase-from-infectious-pa-peer-reviewed-article-DDDT
_version_ 1818424620147015680
author Bello-Pérez M
Falco A
Galiano V
Coll J
Perez L
Encinar JA
author_facet Bello-Pérez M
Falco A
Galiano V
Coll J
Perez L
Encinar JA
author_sort Bello-Pérez M
collection DOAJ
description Melissa Bello-Pérez,1 Alberto Falcó,1 Vicente Galiano,2 Julio Coll,3 Luis Perez,1 José Antonio Encinar1 1Molecular and Cell Biology Institute (IBMC), Miguel Hernández University (UMH), Elche, Spain; 2Department of Physics and Computer Architecture, Miguel Hernández University (UMH), Elche, Spain; 3Department of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Madrid, Spain Introduction: Infectious pancreatic necrosis virus (IPNV) causes serious losses in several fish species of commercial interest. IPNV is a non-enveloped double-stranded RNA virus with a genome consisting of two segments A and B. Segment B codes for the VP1 protein, a non-canonical RNA-dependent RNA polymerase that can be found both in its free form and linked to the end of genomic RNA, an essential enzyme for IPNV replication. Materials and methods: We take advantage of the knowledge over the allosteric binding site described on the surface of the thumb domain of Hepatitis C virus (HCV) polymerase to design new non-nucleoside inhibitors against the IPNV VP1 polymerase. Results: Molecular docking techniques have been used to screen a chemical library of 23,760 compounds over a defined cavity in the surface of the thumb domain. Additional ADMET (absorption, distribution, metabolism, excretion, and toxicity) filter criteria has been applied. Conclusion: We select two sets of 9 and 50 inhibitor candidates against the polymerases of HCV and IPNV, respectively. Two non-toxic compounds have been tested in vitro with antiviral capacity against IPNV Sp and LWVRT60 strains in the low µM range with different activity depending on the IPNV strain used. Keywords: IPNV, HCV, antiviral drugs, non-nucleoside inhibitors, RdRp, molecular docking
first_indexed 2024-12-14T14:00:56Z
format Article
id doaj.art-8d72c83e3dc3410cb443e310a3ab9a5d
institution Directory Open Access Journal
issn 1177-8881
language English
last_indexed 2024-12-14T14:00:56Z
publishDate 2018-07-01
publisher Dove Medical Press
record_format Article
series Drug Design, Development and Therapy
spelling doaj.art-8d72c83e3dc3410cb443e310a3ab9a5d2022-12-21T22:58:43ZengDove Medical PressDrug Design, Development and Therapy1177-88812018-07-01Volume 122337235939566Discovery of nonnucleoside inhibitors of polymerase from infectious pancreatic necrosis virus (IPNV)Bello-Pérez MFalco AGaliano VColl JPerez LEncinar JAMelissa Bello-Pérez,1 Alberto Falcó,1 Vicente Galiano,2 Julio Coll,3 Luis Perez,1 José Antonio Encinar1 1Molecular and Cell Biology Institute (IBMC), Miguel Hernández University (UMH), Elche, Spain; 2Department of Physics and Computer Architecture, Miguel Hernández University (UMH), Elche, Spain; 3Department of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Madrid, Spain Introduction: Infectious pancreatic necrosis virus (IPNV) causes serious losses in several fish species of commercial interest. IPNV is a non-enveloped double-stranded RNA virus with a genome consisting of two segments A and B. Segment B codes for the VP1 protein, a non-canonical RNA-dependent RNA polymerase that can be found both in its free form and linked to the end of genomic RNA, an essential enzyme for IPNV replication. Materials and methods: We take advantage of the knowledge over the allosteric binding site described on the surface of the thumb domain of Hepatitis C virus (HCV) polymerase to design new non-nucleoside inhibitors against the IPNV VP1 polymerase. Results: Molecular docking techniques have been used to screen a chemical library of 23,760 compounds over a defined cavity in the surface of the thumb domain. Additional ADMET (absorption, distribution, metabolism, excretion, and toxicity) filter criteria has been applied. Conclusion: We select two sets of 9 and 50 inhibitor candidates against the polymerases of HCV and IPNV, respectively. Two non-toxic compounds have been tested in vitro with antiviral capacity against IPNV Sp and LWVRT60 strains in the low µM range with different activity depending on the IPNV strain used. Keywords: IPNV, HCV, antiviral drugs, non-nucleoside inhibitors, RdRp, molecular dockinghttps://www.dovepress.com/discovery-of-nonnucleoside-inhibitors-of-polymerase-from-infectious-pa-peer-reviewed-article-DDDTIPNVHCVantiviral drugsnon-nucleoside inhibitorsRNA-dependent RNA polymerasemolecular docking
spellingShingle Bello-Pérez M
Falco A
Galiano V
Coll J
Perez L
Encinar JA
Discovery of nonnucleoside inhibitors of polymerase from infectious pancreatic necrosis virus (IPNV)
Drug Design, Development and Therapy
IPNV
HCV
antiviral drugs
non-nucleoside inhibitors
RNA-dependent RNA polymerase
molecular docking
title Discovery of nonnucleoside inhibitors of polymerase from infectious pancreatic necrosis virus (IPNV)
title_full Discovery of nonnucleoside inhibitors of polymerase from infectious pancreatic necrosis virus (IPNV)
title_fullStr Discovery of nonnucleoside inhibitors of polymerase from infectious pancreatic necrosis virus (IPNV)
title_full_unstemmed Discovery of nonnucleoside inhibitors of polymerase from infectious pancreatic necrosis virus (IPNV)
title_short Discovery of nonnucleoside inhibitors of polymerase from infectious pancreatic necrosis virus (IPNV)
title_sort discovery of nonnucleoside inhibitors of polymerase from infectious pancreatic necrosis virus ipnv
topic IPNV
HCV
antiviral drugs
non-nucleoside inhibitors
RNA-dependent RNA polymerase
molecular docking
url https://www.dovepress.com/discovery-of-nonnucleoside-inhibitors-of-polymerase-from-infectious-pa-peer-reviewed-article-DDDT
work_keys_str_mv AT belloperezm discoveryofnonnucleosideinhibitorsofpolymerasefrominfectiouspancreaticnecrosisvirusipnv
AT falcoa discoveryofnonnucleosideinhibitorsofpolymerasefrominfectiouspancreaticnecrosisvirusipnv
AT galianov discoveryofnonnucleosideinhibitorsofpolymerasefrominfectiouspancreaticnecrosisvirusipnv
AT collj discoveryofnonnucleosideinhibitorsofpolymerasefrominfectiouspancreaticnecrosisvirusipnv
AT perezl discoveryofnonnucleosideinhibitorsofpolymerasefrominfectiouspancreaticnecrosisvirusipnv
AT encinarja discoveryofnonnucleosideinhibitorsofpolymerasefrominfectiouspancreaticnecrosisvirusipnv